These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 6986928

  • 1. The politics of health cost containment: end-stage renal disease.
    Rettig RA.
    Bull N Y Acad Med; 1980; 56(1):115-38. PubMed ID: 6986928
    [No Abstract] [Full Text] [Related]

  • 2. Justice and cost-containment in end-stage renal disease.
    Johnstone BV.
    J Contemp Health Law Policy; 1987; 3():65-84. PubMed ID: 10301637
    [No Abstract] [Full Text] [Related]

  • 3. Medicare program; end-stage renal disease prospective payment system. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2010 Aug 12; 75(155):49029-214. PubMed ID: 20712086
    [Abstract] [Full Text] [Related]

  • 4. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N, Guest S, Wong L, Inglese G, Bhattacharyya SK, Gehr T, Walker DR, Golper T.
    Clin Ther; 2009 Apr 12; 31(4):880-8. PubMed ID: 19446160
    [Abstract] [Full Text] [Related]

  • 5. The first DRG: lessons from the end stage renal disease program for the prospective payment system.
    Maxwell JH, Sapolsky HM.
    Inquiry; 1987 Apr 12; 24(1):57-67. PubMed ID: 2951335
    [Abstract] [Full Text] [Related]

  • 6. Cost comparison of in-center dialysis, home dialysis, and transplantation in the Nashville area.
    Thompson K.
    Nephrol Nurse; 1980 Apr 12; 2(6):23-4. PubMed ID: 7003421
    [No Abstract] [Full Text] [Related]

  • 7. Health policy report. Funding the End-Stage Renal-Disease Program.
    Iglehart JK.
    N Engl J Med; 1982 Feb 25; 306(8):492-6. PubMed ID: 7035954
    [No Abstract] [Full Text] [Related]

  • 8. Management of end-stage renal disease in Alabama.
    Melnick S.
    Ala J Med Sci; 1983 Oct 25; 20(4):456-9. PubMed ID: 6359945
    [No Abstract] [Full Text] [Related]

  • 9. Who should be paying for vitamin D analogues--Medicare or the patients?
    Grotegut J.
    Nephrol Nurs J; 2006 Oct 25; 33(3):345-6. PubMed ID: 16912996
    [No Abstract] [Full Text] [Related]

  • 10. Economic evaluation of dialysis therapies.
    Klarenbach S, Manns B.
    Semin Nephrol; 2009 Sep 25; 29(5):524-32. PubMed ID: 19751898
    [Abstract] [Full Text] [Related]

  • 11. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS.
    Semin Dial; 2004 Sep 25; 17(2):125-30. PubMed ID: 15043614
    [Abstract] [Full Text] [Related]

  • 12. A cost effectiveness analysis of the treatment of end stage renal failure.
    Croxson BE, Ashton T.
    N Z Med J; 1990 Apr 25; 103(888):171-4. PubMed ID: 2109846
    [Abstract] [Full Text] [Related]

  • 13. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C.
    Am J Kidney Dis; 2002 Sep 25; 40(3):611-22. PubMed ID: 12200814
    [Abstract] [Full Text] [Related]

  • 14. Comments on proposed conditions for coverage focus on patient care, training, facility upgrades.
    Leiby M.
    Nephrol News Issues; 2005 Aug 25; 19(9):15-7. PubMed ID: 16173298
    [No Abstract] [Full Text] [Related]

  • 15. The public cost of kidney disease.
    Ruchlin HS.
    Soc Work Health Care; 1984 Aug 25; 9(4):1-9. PubMed ID: 6385310
    [Abstract] [Full Text] [Related]

  • 16. The organization of medical care. Lessons from the Medicare end stage renal disease program.
    Levinsky NG.
    N Engl J Med; 1993 Nov 04; 329(19):1395-9. PubMed ID: 8413437
    [No Abstract] [Full Text] [Related]

  • 17. PPS changes dialysis coverage rules.
    Smith E, Burns M.
    Provider; 1999 Dec 04; 25(12):57, 59. PubMed ID: 10747513
    [No Abstract] [Full Text] [Related]

  • 18. Predicting treatment costs and life expectancy for end-stage renal disease.
    Stange PV, Sumner AT.
    N Engl J Med; 1978 Feb 16; 298(7):372-8. PubMed ID: 340947
    [Abstract] [Full Text] [Related]

  • 19. Entitlement to Medicare benefits based on end-stage renal disease: final regulation.
    Fed Regist; 1978 Sep 28; 43(189):44801-4. PubMed ID: 10297231
    [No Abstract] [Full Text] [Related]

  • 20. Cost containment and patient choice in the end stage renal disease program.
    Orr ML.
    AANNT J; 1982 Dec 28; 9(6):11-5. PubMed ID: 6756420
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.